ALK Chromosome 2

ALK receptor tyrosine kinase
365 variants 365 Health Risk

Upload your DNA to see your personal genotypes for variants in ALK.

What This Gene Does
This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
Gene Info
Gene Group
"Receptor tyrosine kinases|CD molecules"
Locus Type
gene with protein product
Location
2p23.2-p23.1
Ensembl
ENSG00000171094
Associated Conditions (14)
Neuroblastoma
susceptibility to
3
Hereditary cancer-predisposing syndrome
Ovarian cancer
ALK-related disorder
Ovarian serous cystadenocarcinoma
Familial isolated pituitary adenoma
Diffuse midline glioma
H3 K27-altered
Malignant tumor of urinary bladder
Lung cancer
Rhabdomyosarcoma
Neoplasm
Key Variants
All Variants (365)
RSID Category Clinical Significance Conditions
RS1431784023 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS143229596 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS143647372 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1437432300 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS144030155 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS144453491 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1444967093 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1446332510 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1450281991 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS145028315 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1453170969 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS145681577 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS145780832 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1465809492 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1466204048 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1466800086 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS147033307 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS147241767 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1475116674 Health Risk Conflicting classifications of pathogenicity Ovarian cancer, Neuroblastoma, susceptibility to
RS147858673 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS148001139 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1484797934 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1489025810 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1490289892 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS149145987 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS149837139 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS150785816 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS150966028 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1553348499 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1553387094 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1553391515 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1553394254 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1553402750 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1558626238 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1558626541 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1572502948 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1572504096 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1573084845 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1573098889 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1573139642 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1573223126 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1573561737 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1663951981 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1664016363 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1664103646 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1665516024 Health Risk Conflicting classifications of pathogenicity Hereditary cancer-predisposing syndrome, Neuroblastoma, susceptibility to
RS1665516730 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1666202984 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1666207064 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1666897900 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
« Prev 1 2 3 4 5 ... 8 Next »
Sign Up to Analyze Your DNA Log In